Spots Global Cancer Trial Database for esophagus cancer
Every month we try and update this database with for esophagus cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity | NCT04500392 | Hypoxia Gastric Cancer Esophagus Cance... Polyp of Colon Colon Cancer | High-flow nasal... Regular nasal c... | 18 Years - 70 Years | RenJi Hospital | |
| Chemotherapy With or Without Surgical Resection in Locally Advanced Esophageal Cancer | NCT00193141 | Esophagus Cance... | Paclitaxel Carboplatin 5-Fluorouracil | 18 Years - | SCRI Development Innovations, LLC | |
| Chemoradiation Versus Esophagectomy for Locally Advanced Esophageal Cancer | NCT02972372 | Esophagus Cance... | CRT surgery | 18 Years - 75 Years | The First Affiliated Hospital of Henan University of Science and Technology | |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors | NCT06010862 | Gastric Cancer Colon Cancer Pancreas Cancer Esophagus Cance... Cholangiocarcin... Lung Cancer Breast Cancer | CEA CAR-T cells CEA CAR-T cells | 18 Years - | Chongqing Precision Biotech Co., Ltd | |
| Neoadjuvant Chemoradiotherapy Combined With PD-1 Antibody in Locally Advanced Esophageal Cancer | NCT04177875 | Esophagus Cance... | Teripalimab | 18 Years - 70 Years | Tongji Hospital | |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies | NCT03638206 | B-cell Acute Ly... Lymphoma Myeloid Leukemi... Multiple Myelom... Hepatoma Gastric Cancer Pancreatic Canc... Mesothelioma Colorectal Canc... Esophagus Cance... Lung Cancer Glioma Melanoma Synovial Sarcom... Ovarian Cancer Renal Carcinoma | CAR-T cell immu... | 4 Years - 70 Years | Shenzhen BinDeBio Ltd. | |
| Evaluation of Full-field Coherence Tomography for ex Vivo Staging and Assessment of Superficial Esophageal Squamous Carcinoma: a Pilot Study | NCT03467529 | Esophagus Cance... | Non interventio... | 18 Years - | Nantes University Hospital | |
| Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01 | NCT03298204 | Esophagus Cance... Chemoradiation Chemotherapy Ef... Radiotherapy Si... | 18 Years - | ChineseAMS | ||
| The Effect of Parenteral Nutrition Supplement on Esophagectomy Patients | NCT01669356 | Esophagus Cance... | Parenteral supp... Enteral Nutriti... | 18 Years - 80 Years | Shanghai Zhongshan Hospital | |
| Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay | NCT02797405 | Sarcoma Rectal Carcinom... Esophagus Cance... | Standard treatm... | 18 Years - | Centre Leon Berard | |
| KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer | NCT03342937 | Gastric Cancer Esophagus Cance... | Oxaliplatin+Cap... | 18 Years - | Duke University | |
| Impact of Dose to Cardiac Substructures on Survival in Patients With Esophageal Cancer Treated With Radiotherapy or Chemoradiotherapy (SATIATION) | NCT05996276 | Esophagus Cance... | 18 Years - | University Hospital, Brest | ||
| Neoadjuvant Chemotherapy Compared With Surgery for Esophageal Carcinoma | NCT05569668 | Esophagus Cance... | Paclitaxel- and... | - | Henan Cancer Hospital | |
| Preoperative Therapy With Oxaliplatin/Docetaxel/Capecitabine and Radiation in Resectable Esophagus Cancer | NCT00193128 | Esophagus Cance... | Oxaliplatin Docetaxel Capecitabine Radiation thera... | 18 Years - | SCRI Development Innovations, LLC | |
| The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1 | NCT05829057 | Esophagus Cance... Bladder Cancer Liver Cancer Ovarian Cancer Small-cell Lung... | Intravenous inj... P-IL-2 plus Ant... | 18 Years - 75 Years | Zhejiang University | |
| Study of NS-9 in Patients With Liver Metastases | NCT00094003 | Liver Neoplasms Neoplasm Metast... Local Neoplasm ... | NS-9 [Poly I: P... | 18 Years - | NS Pharma, Inc. | |
| Imaging Study Compare 4DCT Image | NCT01626001 | Esophagus Cance... Lung Cancer | 4D CT scans | 18 Years - | M.D. Anderson Cancer Center | |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | NCT02552121 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer... Esophagus Cance... Lung Cancer (NS... | Tisotumab vedot... | 18 Years - | Seagen Inc. | |
| Phase II/III Study Comparing Chemoradiotherapy With Radiotherapy in Elderly Patients With Esophageal or Esophagogastric Cancer - 3JECROG P-01 | NCT02979691 | Esophagus Cance... Esophagogastric... Radiotherapy; C... Chemoradiation | SIB-IMRT S-1 | 70 Years - | ChineseAMS | |
| Carrelizumab Combined With Chemotherapy for Adjuvant Therapy of Esophageal Squamous Cell Carcinoma | NCT05637268 | Esophagus Cance... | Camrelizumab Paclitaxel Cisplatin | 18 Years - 70 Years | Tianjin Medical University Cancer Institute and Hospital | |
| Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01 | NCT03298204 | Esophagus Cance... Chemoradiation Chemotherapy Ef... Radiotherapy Si... | 18 Years - | ChineseAMS | ||
| DC Vaccine Combined With CIK Cells in Patients With Esophagus Cancer | NCT02693236 | Esophagus Cance... | adenovirus-tran... | 18 Years - 70 Years | Affiliated Hospital to Academy of Military Medical Sciences | |
| Measuring Cell Free DNA During the Course of Treatment for Esophageal Cancer as a Marker of Response and Recurrence | NCT03108885 | Esophageal Neop... Esophageal Neop... Esophageal Neop... Cancer of Esoph... Cancer of the E... Esophageal Canc... Esophagus Cance... Neoplasm, Esoph... | Blood and Tissu... | 19 Years - | Mayo Clinic | |
| IMRT Tomotherapy for Esophagus Cancer | NCT00593723 | Esophagus Cance... | IMRT | 18 Years - | Washington University School of Medicine | |
| Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies | NCT00496860 | Progressive Met... | ALT-801 | 18 Years - | Altor BioScience | |
| Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S | NCT04430842 | Astrocytoma Brain Cancer Brain Metastase... Bladder Cancer Breast Cancer Cervical Cancer Cholangiocarcin... Colorectal Canc... Esophagus Cance... Gastric Cancer Head and Neck C... Kidney Cancer Liver Cancer Lung Cancer Melanoma Ovarian Cancer Pancreatic Canc... Pleural Mesothe... Prostate Cancer Sarcoma Tongue Cancer Thymic Carcinom... Urinary Tract C... | QBS10072S | 18 Years - | Quadriga Biosciences, Inc. | |
| A Clinical Study of Non-curative Resection Plus Radiotherapy After Endoscopic ESD for Superficial Esophageal Squamous Cell Carcinoma | NCT06160557 | Esophagus Cance... Radiotherapy Endoscopic Muco... | 18 Years - 75 Years | Fujian Medical University | ||
| MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy | NCT02988921 | Esophagus Cance... Esophagogastric... | MRI and CT Ratiotherapy Paclitaxel, pla... | 18 Years - | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Tumor Antigen-sensitized DC Vaccine as an Adjuvant Therapy for Esophagus Cancer | NCT05023928 | Carcinoma Esophagus Cance... | Tumor antigen-s... | 18 Years - 75 Years | Sichuan University | |
| Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer | NCT06430658 | Esophagus Cance... | Tislelizumab (B... | 18 Years - 75 Years | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Influence of Different Light Dose on the Adverse Effect of Swallowing for Esophageal Carcinoma | NCT05174117 | Esophagus Cance... | single irradiat... Double irradiat... | 18 Years - 80 Years | The First Affiliated Hospital of Henan University of Science and Technology | |
| Imaging Study Compare 4DCT Image | NCT01626001 | Esophagus Cance... Lung Cancer | 4D CT scans | 18 Years - | M.D. Anderson Cancer Center | |
| Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17) | NCT04764227 | Esophagus Cance... Esophageal Squa... Chemoradiothera... Radiation Thera... Postoperative | Paclitaxel Carboplatin Radiotherapy | 18 Years - 75 Years | Fudan University | |
| Mayo Clinic Upper Digestive Disease Survey | NCT02530983 | Esophageal Neop... Cancer of Esoph... Cancer of the E... Esophageal Canc... Esophagus Cance... Neoplasm, Esoph... Esophagectomy Abnormalities, ... Digestive Syste... | Mayo Clinic Upp... Upper Digestive... | 18 Years - | Mayo Clinic | |
| Chemoradiotherapy Plus Immunotherapy Followed by Surgery for Esophageal Cancer | NCT04776590 | Esophagus Cance... Neoadjuvant The... | Tislelizumab | 18 Years - 70 Years | Wuhan Union Hospital, China | |
| Acupuncture Effect on Dumping Syndrome in Esophagus Cancer Patients With Feeding Jejunostomy | NCT05801666 | Esophagus Cance... Acupuncture | Acupuncture | 20 Years - 80 Years | China Medical University, Taiwan | |
| Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer | NCT03777813 | Esophagus Cance... Unresectable Ma... | Durvalumab IMRT 50 Gy + FO... | 18 Years - | UNICANCER | |
| Proton Therapy for Esophageal Cancer | NCT01684904 | Esophagus Cance... | Proton radiatio... | 18 Years - | Loma Linda University | |
| Tumour and HEalthy Tissues DOse-response and Radiosensitivity Assay | NCT02797405 | Sarcoma Rectal Carcinom... Esophagus Cance... | Standard treatm... | 18 Years - | Centre Leon Berard | |
| Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors | NCT04902872 | Solid Tumor, Ad... Epithelial Ovar... Small Cell Lung... Breast Cancer Colorectal Canc... Pancreas Cancer Appendix Cancer Non-small Cell ... Gastric Cancer Esophagus Cance... Urothelial Carc... Sarcoma | CBX-12 | 18 Years - | Cybrexa Therapeutics | |
| Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy | NCT06147180 | Esophagus Cance... Esophagectomy Quality of Life Survival | - | Qilu Hospital of Shandong University | ||
| Phase II Evaluation of Exhaled Nitric Oxide (NO) | NCT01392144 | Lung Cancer | Nitric oxide br... Questionnaires | 18 Years - | M.D. Anderson Cancer Center | |
| Radiochemotherapy in Elderly Patients With Oesophagus Cancer | NCT02879227 | Esophagus Cance... | Cisplatin Oxaliplatin | 75 Years - | Centre Hospitalier Universitaire de Besancon | |
| Prediction of Lymphatic Metastasis in Esophageal Cancer by CT Radiomics | NCT03237130 | Esophagus Cance... | preoperative en... | - | Peking University Cancer Hospital & Institute | |
| Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer | NCT00318903 | Esophageal Canc... Cancer of the E... Esophagus Cance... Esophageal Neop... Cancer of Esoph... | Irinotecan (dru... Taxotere (drug) Radiotherapy (p... Esophagectomy (... | 19 Years - | University of Alabama at Birmingham | |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | NCT02001623 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer... Esophagus Cance... Lung Cancer(NSC... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| Proton Therapy for Esophageal Cancer | NCT01684904 | Esophagus Cance... | Proton radiatio... | 18 Years - | Loma Linda University | |
| Rhomboid Intercostal and Subserratum Plane Block for Minimally Invasive Esophagectomy | NCT06092944 | Esophagus Cance... | Catheterization Single nerve bl... Continuous nerv... PCIA | 18 Years - 75 Years | Fuling Central Hospital of Chongqing City | |
| Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | NCT02001623 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer... Esophagus Cance... Lung Cancer(NSC... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| Proton Beam Therapy in the Treatment of Esophageal Cancer | NCT03482791 | Esophagus Cance... Esophageal Canc... Cancer of the E... | Proton beam the... Patient-Reporte... | 18 Years - | Washington University School of Medicine | |
| Advanced Oesophageal Cancer Study to Compare Quality of Life and Palliation of Dysphagia. | NCT00193882 | Esophagus Cance... | Cisplatin Radiotherapy 5-Fluorouracil | 18 Years - | Trans Tasman Radiation Oncology Group | |
| DC Vaccine Combined With CIK Cells in Patients With Esophagus Cancer | NCT02693236 | Esophagus Cance... | adenovirus-tran... | 18 Years - 70 Years | Affiliated Hospital to Academy of Military Medical Sciences | |
| The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy | NCT00270166 | Anemia Multiple Myelom... Lymphoma Breast Cancer Ovarian Cancer Carcinoma, Smal... Esophagus Cance... Prostate Cancer Neoplasm | epoetin alfa | 18 Years - 80 Years | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal Cancer | NCT06097078 | Esophageal Canc... Esophagus Cance... Anastomotic Lea... | Eso-SPONGE® | 18 Years - | Aesculap AG | |
| Comparison of Long-term Survival and Quality of Life After Minimally Invasive Esophagectomy Versus Open Esophagectomy | NCT06147180 | Esophagus Cance... Esophagectomy Quality of Life Survival | - | Qilu Hospital of Shandong University | ||
| The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study | NCT04075305 | Oncology Breast Cancer Prostate Cancer Gynecologic Can... Brain Tumor Brain Cancer Gynecologic Tum... Prostate Tumor Prostate Neopla... Breast Tumor Radiation Toxic... Quality of Life Rectal Cancer Rectal Tumor Rectal Neoplasm... Lung Cancer Lung Tumor Lung Neoplasm Esophageal Canc... Esophagus Cance... Esophageal Tumo... Esophageal Neop... Esophagus Tumor Esophagus Neopl... Pancreatic Canc... Pancreatic Tumo... Pancreatic Neop... Head and Neck C... Head and Neck N... Head and Neck T... Tumor Neoplasms Bladder Cancer Bladder Neoplas... Liver Cancer Liver Neoplasms Liver Metastase... Oligometastases | Radiation thera... | 18 Years - | UMC Utrecht | |
| Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer | NCT04821765 | Esophagus Cance... Chemoradiothera... Oligometastatic... Immunotherapy | PD-1 antibody Chemoradiation Albumin-Bound P... Cisplatin | 18 Years - | ChineseAMS | |
| Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer | NCT00660205 | Thrombosis Deep Venous Thr... Pulmonary Embol... Venous Thromboe... Pancreas Cancer Esophagus Cance... Gastric Cancer | 15 Years - 85 Years | University of Aarhus | ||
| Definitive (Chemo)Radiotherapy for Patients With Esophageal Cancer - 3JECROG R-01 | NCT03298204 | Esophagus Cance... Chemoradiation Chemotherapy Ef... Radiotherapy Si... | 18 Years - | ChineseAMS | ||
| Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer | NCT04046575 | Esophagus Cance... Esophageal Canc... Cancer of the E... | Intensity Modul... Carboplatin MD Anderson Sym... EuroQol (EQ-5D) SF-12 MOS Social Supp... CES-D Blood for ctDNA... Blood for SCCA Paclitaxel | 18 Years - | Washington University School of Medicine | |
| Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes | NCT04907643 | Cancer Pain Visceral Pain Gastrointestina... Cancer of Gastr... Small Intestine... Pancreas Cancer Liver Cancer Colon Cancer Biliary Tract C... Stomach Cancer Rectum Cancer Peritoneal Canc... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Gastrointestina... Small Intestine... Small Intestine... Small Intestine... Pancreas Cancer... Pancreas Cancer... Pancreas Cancer... Pancreas Cancer... Liver Cancer St... Liver Cancer St... Liver Cancer St... Liver Cancer St... Colon Cancer St... Colon Cancer St... Stomach Cancer ... Stomach Cancer ... Stomach Cancer ... Rectum Cancer, ... Gastrointestina... Anal Cancer Anal Cancer Sta... Anal Cancer Sta... Anal Cancer Rec... Anal Cancer Met... Anal Cancer, St... Anal Cancer, St... Appendix Cancer Ampullary Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Bile Duct Cance... Carcinoid Tumor Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Carcinoid Tumor... Large Intestine... Esophagus Cance... Esophagus Cance... Esophagus Cance... Esophagus Cance... Gallbladder Can... Gallbladder Can... Gallbladder Can... Gastric (Stomac... Neuroendocrine ... Peritoneum Canc... Rectal Cancer Esophagus Cance... Esophagus Cance... Gallbladder Can... Gallbladder Can... Bile Duct Cance... Bile Duct Cance... | PICO G2 4k | 18 Years - 99 Years | Cedars-Sinai Medical Center | |
| MRI and CT Simulation in the Evaluation of Tumor Response and Target Volume Definition for Esophageal or Esophagogastric Cancer Patients Undergoing Chemoradiotherapy | NCT02988921 | Esophagus Cance... Esophagogastric... | MRI and CT Ratiotherapy Paclitaxel, pla... | 18 Years - | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | |
| Venous Thromboembolism and Haemostatic Disturbances in Patients With Upper Gastrointestinal Cancer | NCT00660205 | Thrombosis Deep Venous Thr... Pulmonary Embol... Venous Thromboe... Pancreas Cancer Esophagus Cance... Gastric Cancer | 15 Years - 85 Years | University of Aarhus | ||
| Proton Therapy for Esophageal Cancer | NCT01684904 | Esophagus Cance... | Proton radiatio... | 18 Years - | Loma Linda University | |
| A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors | NCT05602792 | Advanced Solid ... Sarcoma HNSCC Breast Cancer Esophagus Cance... NSCLC Non-melanoma Sk... | T3011 T3011 T3011 T3011 T3011 T3011 T3011 | 18 Years - | ImmVira Pharma Co. Ltd | |
| Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. | NCT03245736 | Ovary Cancer Cervix Cancer Endometrium Can... Bladder Cancer Prostate Cancer Esophagus Cance... Lung Cancer, No... Squamous Cell C... | Tisotumab Vedot... | 18 Years - | Seagen Inc. | |
| Adverse Events During Upper Gastrointestinal Endoscopy | NCT01979549 | Patients Need U... Peptic Ulcer Gastric Cancer Esophagus Cance... Oesophagitis | 18 Years - | RenJi Hospital | ||
| Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans | NCT05591053 | Esophagus Cance... Esophageal Canc... Esophageal Neop... Esophageal Dise... Esophageal Aden... Esophageal Squa... Esophagus SCC Esophagus Tumor Esophagus Adeno... Esophagus Neopl... | ActivSight | 18 Years - | Activ Surgical | |
| Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus | NCT00165191 | Adenocarcinoma ... Adenocarcinoma ... Adenocarcinoma ... | Doxorubicin Cisplatin 5-fluorouracil | 18 Years - | Dana-Farber Cancer Institute | |
| Different Anesthetic Managements of Esophageal Resection and Reconstruction | NCT02961140 | Anesthesia Esophagus Cance... Postoperative C... | Cardiac Output ... Cardiac Output ... | 35 Years - 65 Years | National Taiwan University Hospital | |
| Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer | NCT04821778 | Esophagus Cance... Esophagogastric... Chemoradiation Targeted Therap... Immunotherapy Chemotherapy Ef... | Radiotherapy Platinum based ... Paclitaxel base... Immunotherapy 5-FU Analog bas... Nimotuzumab | 18 Years - | ChineseAMS | |
| The Efficacy and Safety of Caffeic Acid for Esophageal Cancer | NCT03070262 | Esophagus Cance... | CA placebo group | 18 Years - | The First Affiliated Hospital of Henan University of Science and Technology | |
| Pre-operative MRI of Esophagus Cancer | NCT03347630 | Esophagus Cance... Diagnoses Disea... | MRI | 18 Years - | University of Lausanne Hospitals | |
| Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant Setting | NCT05615129 | Esophagus Cance... | 18 Years - 78 Years | Guangdong Provincial People's Hospital | ||
| Exosome-based Liquid Biopsies for Upper Gastrointestinal Cancers Diagnosis | NCT06278064 | Gastric Cancer Esophagus Cance... | Gastric Cancer Esophagus Cance... | - | Beijing Friendship Hospital | |
| Prediction of Lymphatic Metastasis in Esophageal Cancer by CT Radiomics | NCT03237130 | Esophagus Cance... | preoperative en... | - | Peking University Cancer Hospital & Institute | |
| A Phase 1 Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies | NCT05861947 | Relapse Advanced Malign... Non Small Cell ... Gastric Cancer Urothelial Carc... Kidney Cancer Colon Cancer Esophagus Cance... | AUR106 | 18 Years - 99 Years | Aurigene Discovery Technologies Limited | |
| Phase I/II Evaluation of a Cancer Lysate Vaccine and Montanide(R) ISA-51 VG With Entinostat and Nivolumab as Adjuvant Therapy Following Chemoradiation Therapy With or Without Surgery for Locally Advanced Esophageal Cancer | NCT05898828 | Neoplasms Esophageal Neop... Esophagus Neopl... Esophagus Cance... Neoplasms, Esop... Esophageal Canc... | Nivolumab Entinostat Montanide(R) IS... H1299 Cell Lysa... | 18 Years - 120 Years | National Institutes of Health Clinical Center (CC) | |
| CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer | NCT05187182 | Gastric Cancer Esophageal Canc... Stomach Cancer Esophagus Cance... Gastroesophagea... | CA-4948 Nivolumab Pembrolizumab Trastuzumab mFOLFOX7 | 18 Years - | Washington University School of Medicine | |
| Phase II Evaluation of Exhaled Nitric Oxide (NO) | NCT01392144 | Lung Cancer | Nitric oxide br... Questionnaires | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
